Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 12;39(7):916-927.
doi: 10.1016/j.ccell.2021.04.002. Epub 2021 Apr 29.

Artificial intelligence for clinical oncology

Affiliations
Review

Artificial intelligence for clinical oncology

Benjamin H Kann et al. Cancer Cell. .

Abstract

Clinical oncology is experiencing rapid growth in data that are collected to enhance cancer care. With recent advances in the field of artificial intelligence (AI), there is now a computational basis to integrate and synthesize this growing body of multi-dimensional data, deduce patterns, and predict outcomes to improve shared patient and clinician decision making. While there is high potential, significant challenges remain. In this perspective, we propose a pathway of clinical cancer care touchpoints for narrow-task AI applications and review a selection of applications. We describe the challenges faced in the clinical translation of AI and propose solutions. We also suggest paths forward in weaving AI into individualized patient care, with an emphasis on clinical validity, utility, and usability. By illuminating these issues in the context of current AI applications for clinical oncology, we hope to help advance meaningful investigations that will ultimately translate to real-world clinical use.

Keywords: artificial intelligence; care pathway; clinical oncology; clinical translation; precision medicine.

PubMed Disclaimer

Conflict of interest statement

Declarations of interests H.J.W.L.A. is a shareholder of and receives consulting fees from Onc.Ai and BMS, outside submitted work. A.H. is a shareholder of and receives consulting fees from Altis Labs, outside submitted work.

Figures

Figure 1:
Figure 1:
Narrow task-specific AI applications addressing a specific touchpoint along the patient pathway, and utilizing a specific data type and AI method.
Figure 2:
Figure 2:
An example cancer patient pathway converges with an ever-increasing data stream. Potential AI applications and exemplary clinical users at each touchpoint are also illustrated.
Figure 3:
Figure 3:
Bridging the AI translational gap between initial model development and routine clinical cancer care by emphasizing and demonstrating three essential concepts: clinical validity, utility, and usability.

Similar articles

Cited by

References

    1. AACR Project GENIE Consortium (2017). AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 7, 818–831. - PMC - PubMed
    1. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, and Winchester DP (2017). The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin 67, 93–99. - PubMed
    1. Arbour KC, Luu AT, Luo J, Rizvi H, Plodkowski AJ, Sakhi M, Huang KB, Digumarthy SR, Ginsberg MS, Girshman J, et al. (2020). Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade. Cancer Discov. - PMC - PubMed
    1. Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L, Tse D, Etemadi M, Ye W, Corrado G, et al. (2019). End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat. Med 25, 954–961. - PubMed
    1. Bari A, Marcheselli L, Sacchi S, Marcheselli R, Pozzi S, Ferri P, Balleari E, Musto P, Neri S, Aloe Spiriti MA, et al. (2010). Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann. Oncol 21, 1486–1491. - PubMed

Publication types